{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:05:57Z","timestamp":1792109157884,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbr.2026.116343","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:27:22Z","timestamp":1782923242000},"page":"116343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats"],"prefix":"10.1016","volume":"514","author":[{"given":"Ulya","family":"Keskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslem","family":"Alt\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4438-5689","authenticated-orcid":false,"given":"Melkan Ka\u011fan","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerime Nur","family":"\u00c7ak\u0131r\u00e7oban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikriye Yasemin","family":"\u00d6zatik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neziha Senem","family":"Ar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Ko\u00e7ak","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"G\u00fcngor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2026.116343_bib1","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.3390\/ijms222212366","article-title":"Diabetes and cognitive impairment: a role for glucotoxicity and dopaminergic dysfunction","volume":"22","author":"Pignalosa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2026.116343_bib2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2026.116343_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12902-019-0359-2","article-title":"Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbr.2026.116343_bib4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2018-01315","article-title":"Cognitive dysfunction in type 1 diabetes mellitus","volume":"104","author":"Shalimova","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib5","article-title":"Type 2 diabetes mellitus and cognitive impairment","volume":"53","author":"Damanik","year":"2021"},{"key":"10.1016\/j.bbr.2026.116343_bib6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2026.116343_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.462","article-title":"Glucagon-like peptide agonists: a prospective review","volume":"7","author":"Mariam","year":"2024","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept","volume":"34","author":"Coskun","year":"2022","journal-title":"Cell. Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101470","article-title":"GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes","volume":"49","author":"Monney","year":"2023","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180226","article-title":"Characterization of cognitive decline in long-duration type 1 diabetes by cognitive, neuroimaging, and pathological examinations","volume":"10","author":"Shah","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbr.2026.116343_bib11","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.3390\/ijms22083878","article-title":"The role of molecular and inflammatory indicators in the assessment of cognitive dysfunction in a mouse model of diabetes","volume":"22","author":"Piatkowska-Chmiel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2026.116343_bib12","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1523\/JNEUROSCI.20-09-03456.2000","article-title":"Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor k B activity in the brain during endotoxemia","volume":"20","author":"Nadeau","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2026.116343_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db09-1163","article-title":"Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes","volume":"59","author":"Marioni","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbr.2026.116343_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-015-9739-0","article-title":"Adiponectin, leptin and IL-1 \u03b2 in elderly diabetic patients with mild cognitive impairment","volume":"31","author":"Gorska-Ciebiada","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2026.116343_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141325","article-title":"Prevalence of cognitive impairment in recently diagnosed type 2 diabetes patients: are chronic inflammatory diseases responsible for cognitive decline?","volume":"10","author":"Lavielle","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.bbr.2026.116343_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/1673-5374.350199","article-title":"Brain-derived neurotrophic factor in main neurodegenerative diseases","volume":"18","author":"Camuso","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbr.2026.116343_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.15562\/bmj.v8i2.1460","article-title":"The role of brain-derived neurotrophic factor (BDNF) in cognitive functions","volume":"8","author":"Silakarma","year":"2019","journal-title":"Bali Med. J."},{"key":"10.1016\/j.bbr.2026.116343_bib18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"6","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbr.2026.116343_bib19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/molecules30040848","article-title":"The role of brain-derived neurotrophic factor as an essential mediator in neuronal functions and the therapeutic potential of its mimetics for neuroprotection in neurologic and psychiatric disorders","volume":"30","author":"Numakawa","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2026.116343_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/dneu.22592","article-title":"Differential effects of transient and sustained activation of BDNF-TrkB signaling","volume":"78","author":"Guo","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.bbr.2026.116343_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1566523218666180302163029","article-title":"Dysfunction in brain-derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"18","author":"Mohammadi","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbr.2026.116343_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2016.04.039","article-title":"Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K\/Akt\/mTOR mediated BDNF\/TrkB pathway","volume":"308","author":"Tao","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2026.116343_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psychres.2016.06.037","article-title":"Schisandra chinensis produces the antidepressant-like effects in repeated corticosterone-induced mice via the BDNF\/TrkB\/CREB signaling pathway","volume":"243","author":"Yan","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2026.116343_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.bbr.2026.116343_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13813455.2023.2274279","article-title":"Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro","volume":"131","author":"Liu","year":"2025","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bbr.2026.116343_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-018-1589-y","article-title":"Assessment of spatial learning and memory in the Barnes maze task in rodents\u2014methodological consideration","volume":"392","author":"Gawel","year":"2019","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116343_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/dev.21130","article-title":"The timing of maternal separation affects morris water maze performance and long-term potentiation in male rats","volume":"56","author":"Cao","year":"2014","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.bbr.2026.116343_bib28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1249\/MSS.0000000000002294","article-title":"Effects of exercise training on anxious\u2013depressive-like behavior in alzheimer rat","volume":"52","author":"Wu","year":"2020","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bbr.2026.116343_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013hormone-receptor agonist retatrutide for obesity \u2014 a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2026.116343_bib30","article-title":"Streptozotocin as a tool for induction of rat models of diabetes: a practical guide","author":"Ghasemi","year":"2023","journal-title":"EXCLI J."},{"key":"10.1016\/j.bbr.2026.116343_bib31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/ijms24021196","article-title":"Diabetic encephalopathy in a preclinical experimental model of type 1 diabetes mellitus: observations in adult female rat","volume":"24","author":"Falvo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2026.116343_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/JOE-22-0106","article-title":"Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice","volume":"255","author":"Lafferty","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbr.2026.116343_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71065","article-title":"Incretin-based therapies in alzheimer\u2019s and parkinson\u2019s disease: advancing neuroprotection with dual and triple agonists\u2014a review","volume":"8","author":"Mohammed","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.bbr.2026.116343_bib34","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40263-025-01226-z","volume":"39","author":"H\u00f6lscher","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2026.116343_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0014-2999(90)90099-R","article-title":"Interleukin-1\u03b2 inhibits long-term potentiation in the CA3 region of mouse hippocampal slices","volume":"181","author":"Katsuki","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2026.116343_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213448","article-title":"Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders","volume":"14","author":"Gonzalez Caldito","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2026.116343_bib37","article-title":"The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2026.116343_bib38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/biom14070872","article-title":"Incretin-based multi-agonist peptides are neuroprotective and anti-inflammatory in cellular models of neurodegeneration","volume":"14","author":"Kopp","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbr.2026.116343_bib39","doi-asserted-by":"crossref","first-page":"E595","DOI":"10.1152\/ajpendo.00236.2023","article-title":"Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets","volume":"325","author":"Folli","year":"2023","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1537898","article-title":"Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus","volume":"19","author":"Dou","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2026.116343_bib41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/ph18050614","article-title":"Antidiabetic GLP-1 receptor agonists have neuroprotective properties in experimental animal models of alzheimer\u2019s disease","volume":"18","author":"Urkon","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbr.2026.116343_bib42","article-title":"Effects of GLP -1 receptor agonists on cognitive function in patients with type 2 diabetes: a systematic review and meta-analysis based on randomized controlled trials","author":"Wan","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbr.2026.116343_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11011-025-01649-z","article-title":"Tirzepatide: a novel therapeutic approach for Alzheimer\u2019s disease","volume":"40","author":"Alshehri","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2026.116343_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cm.21812","article-title":"Tau and neurodegeneration","volume":"81","author":"Goedert","year":"2024","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.bbr.2026.116343_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1551273","article-title":"New progress on the role and mechanism of tau protein in Alzheimer\u2019s disease and depression","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2026.116343_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nicl.2012.09.004","article-title":"Abnormalities in the brain of streptozotocin-induced type 1 diabetic rats revealed by diffusion tensor imaging","volume":"1","author":"Huang","year":"2012","journal-title":"NeuroImage Clin."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432826003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:40:07Z","timestamp":1786552807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432826003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"alternative-id":["S0166432826003190"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116343","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2026.116343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116343"}}